🔗 Share this article

A shadow economy for unlicensed slimming drugs is being driven by social media fitness personalities and vendors on communication apps, based on recent findings.

Investigational Treatment Gaining Traction Via Social Media

The experimental drug, which remains in clinical trials, is being advertised by social media influencers for its supposed fat-burning effects. Viewers are encouraged to contact these accounts directly for source information, while also receiving discount codes.

Thriving Trade on Messaging Platforms

Separately, a flourishing market exists on messaging services, where communities with thousands of participants share comparison photos, injection guides and assertions of rapid UK delivery. Vendors market the substance there before redirecting customers to WhatsApp for purchases.

Learning About The Experimental Drug

Retatrutide is an experimental injectable developed by American pharmaceutical company Eli Lilly. The treatment targets three gut hormones – GLP-1, glucose-dependent insulinotropic polypeptide and glucagon. Early trials suggest it could help individuals lose up to a quarter of their total weight. Referred to as the “triple G”, the drug is being hailed digitally as the next Ozempic.

Medical Professionals Voice Concerns

However, doctors and pharmacists have cautions that the sale of what remains an unapproved drug in the UK is worrisome and could result in users administering substances of unknown origin.

Several experts stated the demand for the experimental drug could be connected to the rising cost of approved weight loss products such as Mounjaro.

Regulatory Position and Enforcement

Selling retatrutide on social media or messaging apps is illegal in the United Kingdom, as it is an unlicensed drug that must not be promoted or distributed for personal consumption under the British medical regulations.

Some content creators try to circumvent the regulations by referring to the substance as a “research chemical” or citing it as “not for human consumption”. The substance is not a controlled drug, but promotion and supply can still violate medicines, marketing, and consumer laws, risking fines, legal action or prison.

Platform Response and Material Removal

According to the social media company, the platform has taken down violative content and prohibited related keywords and search suggestions. The company stated it was committed to keeping the service secure and investing in strengthening compliance measures.

Digital Trading Operations

Research also found groups with up to nine thousand participants selling the experimental drug using the platform's built-in search feature, which functions like a online catalog. Typing “retatrutide” instantly displays groups with thousands of users, filled with photos of slimming results, positive reviews and step-by-step instructions for mixing or administering at residence.

Within minutes of joining one group, a seller shared WhatsApp details, where the majority of transactions take place. The vendor provided an instruction manual and guaranteed shipping within 48 hours. When questioned whether the product was authentic, one vendor responded: “You can’t be sure.” Another provided a image of a supposed testing documentation. None asked about weight, medical conditions or previous experience.

Product Details and Costs

Inside these groups, messages display black plastic parcels with Royal Mail labels, stating to include fresh supplies. One communication stated: “It took eight of us to load them this morning.”

Customers can choose between dry substance containers, mixed at residence with sterile water, or pre-filled injectors typically priced at 160 pounds for 20mg. When questioned how long a injector should last, vendors give conflicting answers ranging from a few weeks to “depends on your body”.

Platform Moderation and Security Measures

A representative for Telegram said it regularly moderated dangerous material on its platform including content that promoted the “misuse of controlled medications”. The organization added that it removed “millions of pieces of harmful content each day”.

Medical Professional Cautions

“Individuals are administering materials they can’t verify. Although the science behind retatrutide is valid, these online versions may not include what they claim,” stated a pharmacy expert, the head of pharmacy at Chemist4U.

A medical professional of an online medical service linked the surge in demand to current price rises for approved weight-loss medications such as Mounjaro. “With prices increasing, patients are using social media. But counterfeit treatments are highly dangerous. You can’t be certain what’s inside or whether the conditions they were made in was clean,” she said.

Her team has previously seen patients harmed by self-injection from unverified suppliers. “We recognize the disappointment, but buying from messaging apps or WhatsApp is gambling with your well-being,” said the doctor. “These substances could be contaminated or improperly measured.”

Producer Position

A spokesperson from Eli Lilly stated the substance was in phase 3 research studies and had not been evaluated or authorized by any regulatory agency globally. “Therefore at this point no one can sell [it] for human use,” they said, adding that any product “misleadingly claiming itself as a Lilly investigational substance not yet approved … may expose patients to potentially significant medical dangers”.